Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Reporter Account
Filter News
Show All Results
News By Country
News By Tag
Virus Remove
Related Tags


February 2012
Fr Th We Tu Mo Su Sa
17 16 15 14 13 12 11

virus News

  + XML/RSS  



By Simon Campbell
The organization would like to highlight the research that is being done in the world of alternative medicine.

By Howard Schwartz
As the popularity of e-readers and e-books grows, so does the proliferation of related scams.

By Brighton Publishing
Brighton Publishing LLC announced the eBook release of debut author’s highly-anticipated, controversial bio-thriller

By Cochrane & Associates, LLC
The environmental and infection control professionals at Clark Seif Clark (CSC) provide services to help prevent outbreaks of norovirus.

By Cochrane & Associates, LLC
Sussex Environmental Health Consultants facilitate averting and identifying sources infectious outbreaks.

By Kingsoft
New BIOS based virus, BMW, wildly spreads for downloading malicious viruses, Trojan and other malicious to infected local computer and, remote control local devices for malicious outbound behaviors.

By Kevin Abbott
RebootThat.com awarded Microsoft Small Business Specialist status. By completing highly technical exams enabling us to help start up and small-to-medium businesses with 5 or more PCs, tackle their business challenges through IT solutions.

By Cochrane & Associates, LLC
The IAQ Video Network produces another educational video about the health effects of exposure to environmental hazards.

By Hackney Communications
Small businesses will have access to comprehensive and affordable computer maintenance, monitoring, security, and backup services

By EC2, Inc.
EC2 helps medical facilities with infection control services to help prevent these costly and sometimes deadly infections.

All Press Releases

By Simon Campbell
The CBCD learned that a new study from the Mayo Clinic states that one factor associated with fibromyalgia symptoms is a patient's weight.

By Simon Campbell
The CBCD just learned that Medivir AB has announced that its cold sore product Xerclear®, is being launched for over-the-counter use by its partner GlaxoSmithKline in Europe.

By Simon Campbell
Scientists from MIT, Rockefeller University and the Medical College of Wisconsin have found a technique to generate liver-like cells made from stem cells.

By Simon Campbell
The Virginia House of Delegates has voted to repeal the law requiring girls to receive the human papillomavirus vaccine.

By Simon Campbell
A new study on the Epstein Barr virus (EBV) and Multiple Sclerosis (MS) suggests that the association may be more complicated than thought.

By Simon Campbell
The Center for the Biology of Chronic Disease (CBCD) wishes to use the experience of certain celebrities to educate the public about the dormant Herpes virus.

By Simon Campbell
Two companies have made a deal with each other that will allow Veregen®, a cream against Genital Warts, to be sold within Turkish borders.

By Simon Campbell
According to the CDC the highest rate of advanced cervical cancer occurs among Latina women between 50 and 79 years of age.

By Cochrane & Associates, LLC
UltraViolet Devices, Inc. (UVDI) recognizes two decades of UV and molecular filtration technological advancements and success.

By Simon Campbell
A recent study found that 72% of physicians don’t know that the HPV vaccine protects against anal cancer.

By Simon Campbell
Evidence of retroviruses and herpes viruses has been found in illegally imported wildlife meat products.

By Simon Campbell
The National Institutes of Health (NIH) scientists have developed a new way to see structures within viruses.

By Simon Campbell
The cause of Multiple Sclerosis (MS) may be the Epstein Barr Virus (EBV). This is according to a new study published in the scientific journal, “Neurology.”

By Simon Campbell
The New England Journal of Medicine has published the results of a study sure to disappoint those hoping for a breakthrough vaccine against Genital Herpes.

By Simon Campbell
Merck Pharmaceuticals announced that it was planning on “making whatever deals are necessary” to make sure the company maintains its lead in developing and manufacturing oral medications to treat the Hepatitis C virus.

By Simon Campbell
The CBCD has learned that treatment of herpes simplex virus type 2 in patients coinfected with herpes and HIV-1 could postpone the progression of HIV.

By Simon Campbell
The Epstein Barr virus may cause Multiple Sclerosis according to an article published in MedPage Today.

By Simon Campbell
A paper published ahead of print in the Journal of Infectious Diseases says that Chronic Hepatitis B virus (HBV) infection almost doubles the risk of AIDS or death in people diagnosed with HIV infection.

By Simon Campbell
The CBCD believes that hard research into the efficacy of some alternative, yet scientific, medical remedies is in order.

By Simon Campbell
The organization would like to highlight the research that is being done in the world of alternative medicine.

By Simon Campbell
The Wistar Institute, a biomedical center with a focus on cancer research and vaccine development, has received a grant of up to $7.4 million dollars to develop a drug against cancers caused by the Epstein Barr Virus (EBV.)

By Simon Campbell
The CBCD has learned that researchers with the University of Utah and the University of Massachusetts have identified the first gene linked to frequent herpes-related cold sores.

By Simon Campbell
The Center for the Biology of Chronic Disease (CBCD) is excited to learn that the National Institute of Health (NIH) is beginning a new, large study on birth defects.

By Howard Schwartz
As the popularity of e-readers and e-books grows, so does the proliferation of related scams.

By Simon Campbell
The Center for the Biology of Chronic Disease (CBCD) is starting a public education endeavor regarding the subject of latent viruses.

By Simon Campbell
A committee convened by the National Academy of Sciences has released a report establishing the first set of criteria for research on chimpanzees.

By Simon Campbell
A major cause of school absence in children aged 11 – 16 is Chronic Fatigue Syndrome (CFS) also known as myalgic encephalitis or ME.

By Simon Campbell
The Society for Neuroscience reported that imaging studies showed aerobic exercise can relieve the pain typically experienced by patients with fibromyalgia (FM) who stop taking pain killing medications.

By Simon Campbell
Bristol-Myers Squibb is now collaborating on the development of a new Hepatitis C therapy with Tibotec Pharmaceuticals.

By Simon Campbell
Director of Gynecologic Cancer Prevention Research Group at UMKC, Dr. Diane Harper M.D. wrote what the CBCD believes are some very valid points regarding HPV vaccination in a guest editorial in The Daily Iowan.

By Simon Campbell
The Center for the Biology of Chronic Disease (CBCD) applauds Danish insulin giant, Novo Nordisk’s decision to stop using live animals in biological product control tests.

By Simon Campbell
A gene called C21orf91 seems to be linked with Herpes Simplex virus type 1.

By Simon Campbell
German researchers believe a substance found in green tea may offer an antiviral strategy to prevent Hepatitis C “reinfection."

By Simon Campbell
The signs and symptoms of Fibromyalgia are still not clearly defined…even today. A debate continues to rage among doctors about whether this illness is real or imagined

By V tech-squad Inc.
V tech-squad is launching www.antiviruscloud.net powered by McAfee Security as a Service and V tech-squad’s 24x7 voice support for consumers and SMB's.

By simon
An Epstein-Barr virus (EBV) vaccine in the early phases of development may prove able to prevent infectious mononucleosis and EBV-associated cancers.

By Antivirus-BUYability
November the 30th is international Computer Security Day. This day start way back in 1988 and is supposed to create awareness of computer related security issues.

By Simon Campbell
The Center for the Biology of Chronic Disease (CBCD) is watching closely the development of a new vaccine to protect against genital herpes.

By Simon Campbell
The Center for the Biology of Chronic Disease (CBCD) recently came across an article published on Sioux City Journal.com. The topic dealt with Fibromyalgia, which is a medical disorder, and a discussion on the ways you can manage it.

By Simon Campbell
The Center for the Biology of Chronic Disease (CBCD) has learned that there is a shortage of Hepatitis B (HBV) vaccine in Nagpur city, India.

By Renata
Privacy Protection is a rogue antivirus program that is installed to random computers with a help of Trojan viruses that are able to infiltrate infections without users’ knowledge. The program imitates being a security tool while being a scam.

By Simon Campbell
Although theCBCD believes that it is better to be at least 59% protected against the flu virus than to not be protected at all, the fact that the flu vaccine is not nearly as effective as previously thought is worrisome.

By Simon Campbell
Center for the Biology of Chronic Disease has Argued This Point for Over 8 Years

By Brighton Publishing
Brighton Publishing LLC announced the eBook release of debut author’s highly-anticipated, controversial bio-thriller

By Simon Campbell
The Center for the Biology of Chronic Disease (CBCD) has learned this week that researchers have “developed a system to “see” the source of pain (inflammation)in sufferers of Fibromyalgia.

By Simon Campbell
Vertex Pharmaceuticals’ new drug, “Incivek” has beaten Merck’s “Victrelis’s” sales by a gigantic margin.

By Simon Campbell
According to a study by the Institute of Cancer Research, testing for the presence of the human papillomavirus (HPV) as part of cervical screening reduces the number of women who don’t really need to go in for further testing by over a third.

By Simon Campbell
The Center for the Biology of Chronic Disease (CBCD) congratulates the success of Agneus, Inc.’s HerpV vaccine study.

By Simon Campbell
Bristol-Myers Squibb Co.'s new drug called BMS-790052 in combination with peginterferon and ribavirin cured up to 83% of patients infected with Hepatitis C.

By Simon Campbell
polyDNA, the makers of Gene-Eden-VIR, congratulates VBI Vaccines on its acquisition of Epixis, a biotechnology company that develops a new generation of Virus-Like Particle vaccines.



Page:



  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
2.8K1.1K1.1K
Click to Share